Literature DB >> 659438

Human adenosine deaminase binding protein. Assay, purification, and properties.

P E Daddona, W N Kelley.   

Abstract

In many human tissues adenosine deaminase exists as a complex composed of two proteins; one protein has adenosine deaminase activity while the other represents a binding protein with no other known binding activity. A rapid, quantitative assay for human adenosine deaminase binding protein has been developed utilizing 125I-labeled calf adenosine deaminase. In addition this binding protein has been purified 1,690-fold from human kidney using adenosine deaminase affinity chromatography and appears to be homogenous by sedimentation equilibrium, sodium dodecyl sulfate, and native polyacrylamide gel electrophoresis. This highly purified binding protein exists as a dimer of native molecular weight 190,000, complexes with calf adenosine deaminase in a ratio of 1:2, respectively, and contains carbohydrate which reacts specifically with phytohemagglutinin and ricin lectins. A second form of this adenosine deaminase binding protein may exist, resulting from degradation of its carbohydrate moiety.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659438

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Purification and characterization of intestinal adenosine deaminase from mice.

Authors:  L S Singh; R Sharma
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

3.  Assignment of adenosine deaminase complexing protein (ADCP) gene(s) to human chromosome 2 in rodent-human somatic cell hybrids.

Authors:  E Herbschleb-Voogt; K H Grzeschik; P L Pearson; P Meera Khan
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblast.

Authors:  L F Barros; J C Bustamante; D L Yudilevich; S M Jarvis
Journal:  J Membr Biol       Date:  1991-01       Impact factor: 1.843

Review 5.  Analysis of normal and mutant forms of human adenosine deaminase - a review.

Authors:  P E Daddona; W N Kelley
Journal:  Mol Cell Biochem       Date:  1980-02-08       Impact factor: 3.396

6.  Ecto-enzyme activity of human erythrocyte adenosine deaminase.

Authors:  K Bielat; G L Tritsch
Journal:  Mol Cell Biochem       Date:  1989-04-11       Impact factor: 3.396

7.  Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.

Authors:  R Hirschhorn; V Roegner; T Jenkins; C Seaman; S Piomelli; W Borkowsky
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

8.  Somatic cell genetics of adenosine deaminase expression and severe combined immunodeficiency disease in humans.

Authors:  G Koch; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.

Authors:  E Richard; F X Arredondo-Vega; I Santisteban; S J Kelly; D D Patel; M S Hershfield
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

10.  A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.

Authors:  M E Morrison; S Vijayasaradhi; D Engelstein; A P Albino; A N Houghton
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.